| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOL | Common Stock | Award | $0 | +3,531 | +11% | $0.000000 | 36,883 | 07 Dec 2023 | Direct | F1 |
| transaction | TOL | Common Stock | Options Exercise | $138,082 | +4,250 | +12% | $32.49 | 41,133 | 07 Dec 2023 | Direct | |
| transaction | TOL | Common Stock | Options Exercise | $295,650 | +9,000 | +22% | $32.85 | 50,133 | 07 Dec 2023 | Direct | |
| transaction | TOL | Common Stock | Sale | $1,199,994 | -13,250 | -26% | $90.57 | 36,883 | 07 Dec 2023 | Direct | F2 |
| transaction | TOL | Common Stock | Sale | $1,106,542 | -12,194 | -33% | $90.74 | 24,689 | 07 Dec 2023 | Direct | F3 |
| transaction | TOL | Common Stock | Tax liability | $129,172 | -1,453 | -5.9% | $88.90 | 23,236 | 07 Dec 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOL | Performance Based Restricted Stock Units | Award | $0 | +12,360 | $0.000000 | 12,360 | 07 Dec 2023 | Common Stock | 12,360 | $0.000000 | Direct | F4, F5 | |
| transaction | TOL | Stock Options (Right to Buy) | Options Exercise | $0 | -4,250 | -100% | $0.000000* | 0 | 07 Dec 2023 | Common Stock | 4,250 | $32.49 | Direct | F6 |
| transaction | TOL | Stock Options (Right to Buy) | Options Exercise | $0 | -9,000 | -100% | $0.000000* | 0 | 07 Dec 2023 | Common Stock | 9,000 | $32.85 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Reflects the number of shares earned in respect of ROE-based performance restricted stock units originally granted on December 21, 2020. On December 7, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the applicable performance metrics, which measured return on equity (ROE) of the Issuer over the three year period from November, 1 2020 to October 31, 2023. Settlement of the shares will occur on December 21, 2023. |
| F2 | Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $90.32 to $90.875. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $90.655 to $90.925. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Reflects the number of shares earned in respect to operational performance restricted stock units originally granted December 19, 2022. On December 7, 2023, the Compensation Committee of the Board of Directors certified the achievement levels of the operational metrics applicable to the award and the number of shares earned based on such results. One quarter of the shares earned vest each anniversary of the grant date, with settlement of 100% of the award on the fourth anniversary. |
| F5 | These performance based restricted stock units vest 25% on each December 19, 2023, 2024, 2025 and 2026. Settlement of 100% of the earned shares is scheduled to occur on December 19, 2026. |
| F6 | Vested 25% on 12/19/2015, 12/19/2016, 12/19/2017 and 12/19/2018. Exercisable as of the vesting date. |
| F7 | Vested 25% on 12/18/2016, 12/18/2017, 12/18/2018 and 12/18/2019. Exercisable as of the vesting date. |